CAS 2095719-92-7

(R)-2-(6-(5-Chloro-2-((tetrahydro-2H-pyran-4-yl)amino)pyrimidin-4-yl)-1-oxoisoindolin-2-yl)-N-((S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl)propanamide

CAS : 2095719-92-7

Formule : C₂₉H₃₁ClFN₅O₅

Degré de pureté : 99%

Couleur et forme : Solid

Masse moléculaire : 584.0383

Ref: IN-DA01LIB0

ERK1/2 inhibitor 2

CAS : 2095719-92-7

ERK1/2 inhibitor 2

Degré de pureté : ≥98%

Masse moléculaire : 584.04g/mol

Ref: 54-BUP04263

ERK1/2 inhibitor 2

CAS : 2095719-92-7

ERK1/2 inhibitor 2 (ASTX029) is a selective and orally bioavailable ERK 1/2 inhibitor, with potential antineoplastic activity.

Formule : C₂₉H₃₁ClFN₅O₅

Degré de pureté : 98.99%

Couleur et forme : Solid

Masse moléculaire : 584.04

Ref: TM-T8472

Erk1/2 inhibitor 2

CAS : 2095719-92-7

Erk1/2 inhibitor 2 is a selective small molecule inhibitor designed to target and inhibit the activity of the extracellular signal-regulated kinases 1 and 2 (Erk1/2). These kinases are critical components of the mitogen-activated protein kinase (MAPK) signaling pathway, which is integral to regulating various cellular processes, including proliferation, differentiation, and survival. The source of Erk1/2 inhibitor 2 is synthetic, produced through meticulous organic synthesis techniques specifically tailored to enhance its selectivity and potency.

Formule : C₂₉H₃₁ClFN₅O₅

Degré de pureté : Min. 95%

Masse moléculaire : 584 g/mol

Ref: 3D-VID71992